Stock CPH CIPHER PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Cipher Pharmaceuticals Inc.

Equities

CPH

CA17253X1050

Market Closed - Toronto S.E.
Other stock markets
 04:00:00 2024-05-02 pm EDT 		5-day change 1st Jan Change
8.68 CAD +1.17% Intraday chart for Cipher Pharmaceuticals Inc. +2.00% +56.68%
Mar. 15 Transcript : Cipher Pharmaceuticals Inc., Q4 2023 Earnings Call, Mar 15, 2024
Mar. 14 Tranche Update on Cipher Pharmaceuticals Inc.'s Equity Buyback Plan announced on November 15, 2023. CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference
NE
Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results
AQ
Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference Call
AQ
Cipher Pharmaceuticals Announces the Commencement of OTCQX Trading
AQ
Cipher Pharmaceuticals Announces Change of Auditor
AQ
Cipher Pharmaceuticals Announces Change of Auditor
AQ
Cipher Pharmaceuticals Announces Normal Course Issuer Bid
AQ
Cipher Pharmaceuticals Reports Strong Sales & Earnings Growth in Q3 2023
AQ
Cipher Pharmaceuticals Schedules Q3 2023 Earnings Release and Conference Call
AQ
Cipher Pharmaceuticals Schedules Q3 2023 Earnings Release and Conference Call
AQ
Cipher Pharmaceuticals Announces Final Results of Substantial Issuer Bid
AQ
Cipher Pharmaceuticals Provides Reminder of the Upcoming Expiration of its Substantial Issuer Bid
AQ
Cipher Pharmaceuticals Announces Intention to Commence Substantial Issuer Bid, Aggregate Price up to $6 Million Canadian Dollars
AQ
Cipher Pharmaceuticals Releases Q2 2023 Results, Announces Launch of Epuris in Mexico
AQ
Cipher Pharmaceuticals Schedules Q2 2023 Earnings Release and Conference Call
AQ
Cipher Pharmaceuticals Schedules Q2 2023 Earnings Release and Conference Call
AQ
Cipher Partner, Moberg Pharma Announces Approval for MOB-015 in the European Union
AQ
Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders
AQ
Cipher Pharmaceuticals : Financial Document
PU
Cipher Pharmaceuticals Reports First Quarter Results, Highlighted by Record Cash Per Share and Strong Financial Flexibility
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CPH Stock
  4. News Cipher Pharmaceuticals Inc.
  5. Press Releases